$CDLX
Cardlytics, Inc.

2023 Q4 Form 10-Q Financial Statement

#000166607123000150 Filed on November 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $89.17M $79.01M
YoY Change 8.08% 8.66%
Cost Of Revenue $41.88M $36.14M
YoY Change 8.51% -3.79%
Gross Profit $47.29M $42.86M
YoY Change 7.7% 21.96%
Gross Profit Margin 53.03% 54.25%
Selling, General & Admin $37.81M $29.72M
YoY Change -4.93% -22.32%
% of Gross Profit 79.96% 69.35%
Research & Development $12.51M $12.43M
YoY Change 1.71% -9.68%
% of Gross Profit 26.46% 29.0%
Depreciation & Amortization $6.695M $5.990M
YoY Change -2.25% -42.78%
% of Gross Profit 14.16% 13.98%
Operating Expenses $73.31M $42.15M
YoY Change 50.2% -18.97%
Operating Profit -$26.02M -$20.65M
YoY Change 430.93% -279.27%
Interest Expense $2.086M -$3.310M
YoY Change -52.11% -36.99%
% of Operating Profit
Other Income/Expense, Net -$3.314M
YoY Change -36.91%
Pretax Income -$100.8M -$23.97M
YoY Change -73.34% -482.42%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$100.8M -$23.97M
YoY Change -73.34% -482.42%
Net Earnings / Revenue -113.09% -30.33%
Basic Earnings Per Share -$0.63
Diluted Earnings Per Share -$2.56 -$0.63
COMMON SHARES
Basic Shares Outstanding 39.25M shares 37.72M shares
Diluted Shares Outstanding 37.98M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $91.83M $90.10M
YoY Change -24.67% -34.95%
Cash & Equivalents $91.83M $90.07M
Short-Term Investments
Other Short-Term Assets $6.097M $7.400M
YoY Change -24.34% -15.63%
Inventory
Prepaid Expenses
Receivables $120.6M $103.3M
Other Receivables $5.379M $4.865M
Total Short-Term Assets $223.9M $205.6M
YoY Change -10.44% -17.48%
LONG-TERM ASSETS
Property, Plant & Equipment $3.323M $3.005M
YoY Change -43.83% -57.69%
Goodwill $277.2M $352.7M
YoY Change -21.41% -47.02%
Intangibles $35.00M $43.12M
YoY Change -34.54% -62.14%
Long-Term Investments
YoY Change
Other Assets $2.735M $1.941M
YoY Change 5.76% -29.08%
Total Long-Term Assets $350.2M $429.3M
YoY Change -20.62% -47.46%
TOTAL ASSETS
Total Short-Term Assets $223.9M $205.6M
Total Long-Term Assets $350.2M $429.3M
Total Assets $574.1M $634.9M
YoY Change -16.94% -40.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.425M $3.479M
YoY Change 17.53% -27.03%
Accrued Expenses $9.587M $9.666M
YoY Change -55.06% -52.98%
Deferred Revenue $2.405M $3.323M
YoY Change 37.35% 10.62%
Short-Term Debt $0.00 $30.00M
YoY Change
Long-Term Debt Due $10.00K $0.00
YoY Change -73.68% -100.0%
Total Short-Term Liabilities $171.1M $179.5M
YoY Change -31.25% -29.59%
LONG-TERM LIABILITIES
Long-Term Debt $257.6M $227.1M
YoY Change 13.95% 0.62%
Other Long-Term Liabilities $10.62M $3.000M
YoY Change 14185.71%
Total Long-Term Liabilities $268.2M $230.1M
YoY Change 1095614.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $171.1M $179.5M
Total Long-Term Liabilities $268.2M $230.1M
Total Liabilities $439.3M $409.6M
YoY Change -8.4% -15.69%
SHAREHOLDERS EQUITY
Retained Earnings -$1.111B -$1.010B
YoY Change 13.79% 68.89%
Common Stock $1.244B $1.230B
YoY Change 5.16% 5.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $134.8M $225.3M
YoY Change
Total Liabilities & Shareholders Equity $574.1M $634.9M
YoY Change -16.94% -40.46%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$100.8M -$23.97M
YoY Change -73.34% -482.42%
Depreciation, Depletion And Amortization $6.695M $5.990M
YoY Change -2.25% -42.78%
Cash From Operating Activities $2.934M $1.190M
YoY Change -122.4% -108.24%
INVESTING ACTIVITIES
Capital Expenditures $3.697M $3.150M
YoY Change 17.25% -195.34%
Acquisitions
YoY Change
Other Investing Activities $2.330M $0.00
YoY Change
Cash From Investing Activities -$1.367M -$3.150M
YoY Change -56.64% -4.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 48.00K 30.00K
YoY Change -126.82% -600.0%
NET CHANGE
Cash From Operating Activities 2.934M 1.190M
Cash From Investing Activities -1.367M -3.150M
Cash From Financing Activities 48.00K 30.00K
Net Change In Cash 1.615M -1.930M
YoY Change -109.83% -89.12%
FREE CASH FLOW
Cash From Operating Activities $2.934M $1.190M
Capital Expenditures $3.697M $3.150M
Free Cash Flow -$763.0K -$1.960M
YoY Change -95.31% -82.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
53475000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
43116000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
352721000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
352721000 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
19925000 usd
CY2023Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
23721000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2586000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1941000 usd
CY2022Q4 us-gaap Assets
Assets
691236000 usd
CY2023Q3 us-gaap Assets
Assets
634916000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3765000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3479000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10486000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11086000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21335000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9666000 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0 usd
CY2023Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
30000000 usd
CY2022Q4 cdlx Financial Institution Share Liability Current
FinancialInstitutionShareLiabilityCurrent
48593000 usd
CY2023Q3 cdlx Financial Institution Share Liability Current
FinancialInstitutionShareLiabilityCurrent
43495000 usd
CY2022Q4 cdlx Customer Incentive Liability
CustomerIncentiveLiability
53983000 usd
CY2023Q3 cdlx Customer Incentive Liability
CustomerIncentiveLiability
48922000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1751000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3323000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4910000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2244000 usd
CY2022Q4 cdlx Contingent Consideration Liability Current
ContingentConsiderationLiabilityCurrent
104121000 usd
CY2023Q3 cdlx Contingent Consideration Liability Current
ContingentConsiderationLiabilityCurrent
27268000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
248944000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
179483000 usd
CY2022Q4 us-gaap Senior Notes
SeniorNotes
226047000 usd
CY2023Q3 us-gaap Senior Notes
SeniorNotes
227139000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4306000 usd
CY2023Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
81000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
9000 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
9000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1182568000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1230458000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5598000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5304000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-976570000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1010436000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
211605000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
225335000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
691236000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
634916000 usd
CY2022Q3 us-gaap Revenues
Revenues
72706000 usd
CY2023Q3 us-gaap Revenues
Revenues
79005000 usd
us-gaap Revenues
Revenues
216039000 usd
us-gaap Revenues
Revenues
220037000 usd
CY2022Q3 cdlx Financial Institution Share And Other Third Party Costs
FinancialInstitutionShareAndOtherThirdPartyCosts
37563000 usd
CY2023Q3 cdlx Financial Institution Share And Other Third Party Costs
FinancialInstitutionShareAndOtherThirdPartyCosts
36144000 usd
cdlx Financial Institution Share And Other Third Party Costs
FinancialInstitutionShareAndOtherThirdPartyCosts
112996000 usd
cdlx Financial Institution Share And Other Third Party Costs
FinancialInstitutionShareAndOtherThirdPartyCosts
108698000 usd
CY2022Q3 cdlx Delivery Costs
DeliveryCosts
9125000 usd
CY2023Q3 cdlx Delivery Costs
DeliveryCosts
7012000 usd
cdlx Delivery Costs
DeliveryCosts
23820000 usd
cdlx Delivery Costs
DeliveryCosts
20451000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18289000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14161000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39634000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15561000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61381000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44907000 usd
cdlx Acquisition And Integration Costs Benefit
AcquisitionAndIntegrationCostsBenefit
-4269000 usd
cdlx Acquisition And Integration Costs Benefit
AcquisitionAndIntegrationCostsBenefit
-8146000 usd
CY2022Q3 cdlx Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-46126000 usd
CY2023Q3 cdlx Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
8281000 usd
cdlx Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-114144000 usd
cdlx Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-15045000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
83149000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10468000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5990000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
30695000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
61186000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-32748000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-580000 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-915000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2406000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1497000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4673000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2399000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10882000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5253000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3314000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6267000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-86985000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33866000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23966000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-86985000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33866000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.95
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32950000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37982000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33455000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35502000 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
6267000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-23966000 usd
us-gaap Net Income Loss
NetIncomeLoss
-86985000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33866000 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3998000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
2261000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
9092000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-294000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10265000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34160000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
211605000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
54000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31561000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15171000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1104000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-294000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33866000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
236112000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
44000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10884000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
80000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
73000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
115609000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
103324000 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
4470000 usd
CY2023Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
4865000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7978000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7260000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
250042000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
205589000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5916000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3005000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6571000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4823000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2878000 usd
CY2022Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
334000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38841000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19972000 usd
CY2022Q3 cdlx Acquisition And Integration Costs Benefit
AcquisitionAndIntegrationCostsBenefit
-1867000 usd
CY2023Q3 cdlx Acquisition And Integration Costs Benefit
AcquisitionAndIntegrationCostsBenefit
78000 usd
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
19765000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
99657000 usd
us-gaap Costs And Expenses
CostsAndExpenses
291182000 usd
us-gaap Costs And Expenses
CostsAndExpenses
252785000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
11520000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-20652000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-75143000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21705000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-77893000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1503000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6087000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3998000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
6267000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
580509000 usd
us-gaap Net Income Loss
NetIncomeLoss
-86985000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33866000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
949000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1153000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30695000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19765000 usd
cdlx Capitalized Contract Cost Amortization Interest Expense
CapitalizedContractCostAmortizationInterestExpense
1192000 usd
cdlx Capitalized Contract Cost Amortization Interest Expense
CapitalizedContractCostAmortizationInterestExpense
1234000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
4230000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
90140000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2807000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
83149000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-15044000 usd
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-1446000 usd
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15082000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10991000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
456000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1114000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
111000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-265000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5814000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-10282000 usd
cdlx Increase Decrease In Financial Institution Share Liability
IncreaseDecreaseInFinancialInstitutionShareLiability
-5836000 usd
cdlx Increase Decrease In Financial Institution Share Liability
IncreaseDecreaseInFinancialInstitutionShareLiability
-4994000 usd
cdlx Increase Decrease In Consumer Incentive Liability
IncreaseDecreaseInConsumerIncentiveLiability
-4248000 usd
cdlx Increase Decrease In Consumer Incentive Liability
IncreaseDecreaseInConsumerIncentiveLiability
-5075000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40803000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3119000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1090000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
393000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
73000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
9170000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
8302000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2274000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12607000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8695000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
30000000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
50050000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
24000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
21000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
397000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
55000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
58000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
40000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
181000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-39808000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20074000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1756000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-94974000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31845000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
233562000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121985000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
138588000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
90140000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
138514000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
90067000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
74000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
73000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
138588000 usd
us-gaap Interest Paid Net
InterestPaidNet
2358000 usd
us-gaap Interest Paid Net
InterestPaidNet
2958000 usd
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
11937000 usd
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
0 usd
CY2023Q3 cdlx First Anniversary Annualized Recurring Revenue Cash Paid
FirstAnniversaryAnnualizedRecurringRevenueCashPaid
50100000 usd
CY2023Q3 cdlx Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered
BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered
2740418 shares
CY2023Q3 cdlx First Anniversary Annualized Recurring Revenue Cash Paid
FirstAnniversaryAnnualizedRecurringRevenueCashPaid
50100000 usd
CY2023Q3 cdlx Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered
BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered
2740418 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Significant items subject to such estimates and assumptions include revenue recognition, internal-use software development costs, stock-based compensation, allowance for doubtful accounts, valuation of acquired intangible assets, valuation of contingent consideration for Bridg, goodwill impairment, income tax including valuation allowance, and contingencies. We base our estimates on historical experience and on assumptions that we believe are reasonable. Changes in facts or circumstances may cause us to change our assumptions and estimates in future periods, and it is possible that actual results could differ from our current or revised future estimates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Macroeconomic Considerations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unfavorable conditions in the economy both in the United States and abroad may negatively affect the growth of our business and our results of operations. For example, macroeconomic events, including the changes in inflation, the U.S. Federal Reserve raising interest rates, disruptions in access to bank deposits or lending commitments due to bank failures, the Russia-Ukraine war and the Israel conflict have led to economic uncertainty globally. Historically, during periods of economic uncertainty and downturns, businesses may slow spending on advertising, which may impact our business and our customers’ businesses.</span></div>The effect of macroeconomic conditions may not be fully reflected in our results of operations until future periods. If, however, economic uncertainty increases or the global economy worsens, our business, financial condition and results of operations may be harmed. For further discussion of the potential impacts of macroeconomic events on our business, financial condition and operating results, see the section titled "Risk Factors.
CY2022Q3 cdlx Acquisition And Integration Costs Benefit
AcquisitionAndIntegrationCostsBenefit
-1900000 usd
CY2023Q3 cdlx Acquisition And Integration Costs Benefit
AcquisitionAndIntegrationCostsBenefit
100000 usd
CY2023Q3 cdlx First Anniversary Annualized Recurring Revenue Cash Paid
FirstAnniversaryAnnualizedRecurringRevenueCashPaid
50100000 usd
CY2023Q3 cdlx Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered
BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered
2740418 shares
CY2023Q3 cdlx First Anniversary Annualized Recurring Revenue Cash Paid
FirstAnniversaryAnnualizedRecurringRevenueCashPaid
50100000 usd
CY2023Q3 cdlx Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered
BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered
2740418 shares
CY2022Q1 us-gaap Distribution Made To Limited Partner Cash Distributions Paid
DistributionMadeToLimitedPartnerCashDistributionsPaid
24000 usd
CY2022Q1 us-gaap Proceeds From Limited Partnership Investments
ProceedsFromLimitedPartnershipInvestments
61000 usd
CY2023Q3 us-gaap Goodwill Gross
GoodwillGross
748963000 usd
CY2023Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
396242000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
352721000 usd
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
83100000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
92300000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
49259000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
43041000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7200000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3400000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21600000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10300000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
154500000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
44732000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
53373000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
3423000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
13603000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
13192000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9674000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3149000 usd
CY2023Q3 cdlx Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
0 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
43041000 usd
CY2022Q3 cdlx Consumer Incentives Expense
ConsumerIncentivesExpense
37700000 usd
CY2023Q3 cdlx Consumer Incentives Expense
ConsumerIncentivesExpense
37600000 usd
cdlx Consumer Incentives Expense
ConsumerIncentivesExpense
100300000 usd
cdlx Consumer Incentives Expense
ConsumerIncentivesExpense
101400000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
67285000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73064000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
200538000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
202820000 usd
CY2022Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
28000 usd
CY2023Q3 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
147000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2084000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3405000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
23700000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
12800000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6571000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4823000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
48000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
20000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
6619000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
4843000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4910000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2244000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4306000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2878000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
38000 usd
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
37000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
3000 usd
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0 usd
CY2023Q2 cdlx Net Rentable Area Leased
NetRentableAreaLeased
77000 sqft
CY2023Q3 cdlx Net Rentable Area Leased
NetRentableAreaLeased
17000 sqft
CY2023Q2 cdlx Reduction Of Minimum Lease Payments
ReductionOfMinimumLeasePayments
1900000 usd
cdlx Lease Reduction In Expense
LeaseReductionInExpense
700000 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q3 us-gaap Line Of Credit
LineOfCredit
30000000 usd
CY2022Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
226047000 usd
CY2023Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
227139000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
226047000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
257139000 usd
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
700000 usd
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
100000 usd
CY2020Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
230000000 usd
CY2020Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0100
CY2020Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
222700000 usd
CY2020Q3 cdlx Adjustments To Additional Paid In Capital Issuance Of Capped Calls
AdjustmentsToAdditionalPaidInCapitalIssuanceOfCappedCalls
26500000 usd
CY2020Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0100
CY2020Q3 us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
10000 numberofdays
CY2020Q3 us-gaap Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
0.98
CY2020Q3 us-gaap Debt Instrument Convertible Conversion Ratio1
DebtInstrumentConvertibleConversionRatio1
11.7457
CY2020Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
85140
CY2020Q3 cdlx Debt Instrument Convertible Redemption Period Days Before Maturity Date
DebtInstrumentConvertibleRedemptionPeriodDaysBeforeMaturityDate
P36D
CY2020Q3 us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
1
CY2023Q3 cdlx Debt Instrument Convertible Threshold Principal Outstanding Amount For Partial Redemption
DebtInstrumentConvertibleThresholdPrincipalOutstandingAmountForPartialRedemption
75000000 usd
CY2020Q3 us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
1
CY2020Q3 cdlx Debt Instrument Required Compliance Period Period After Written Notice
DebtInstrumentRequiredCompliancePeriodPeriodAfterWrittenNotice
P60D
CY2020Q3 cdlx Debt Instrument Convertible Percentage Of Holders To Require Written Notice Of Noncompliance
DebtInstrumentConvertiblePercentageOfHoldersToRequireWrittenNoticeOfNoncompliance
0.25
CY2020Q3 cdlx Debt Instrument Convertible Redemption Requirement Amount Of Other Debt Called Due
DebtInstrumentConvertibleRedemptionRequirementAmountOfOtherDebtCalledDue
35000000 usd
CY2020Q3 cdlx Debt Instrument Convertible Percentage Of Holders To Require Written Notice Of Noncompliance
DebtInstrumentConvertiblePercentageOfHoldersToRequireWrittenNoticeOfNoncompliance
0.25
cdlx Debt Instrument Convertible Percentage Of Holders To Require Written Notice Of Noncompliance
DebtInstrumentConvertiblePercentageOfHoldersToRequireWrittenNoticeOfNoncompliance
0.25
cdlx Debt Instrument Convertible Covenant Noncompliance Period Of Additional Interest
DebtInstrumentConvertibleCovenantNoncompliancePeriodOfAdditionalInterest
P365D
cdlx Debt Instrument Convertible Liability Component Discount Rate
DebtInstrumentConvertibleLiabilityComponentDiscountRate
0.0650
CY2022Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
575000 usd
CY2023Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
575000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1725000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1725000 usd
CY2022Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
365000 usd
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
365000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1095000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1096000 usd
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
940000 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
940000 usd
CY2022Q2 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
164277000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
2820000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
2821000 usd
CY2022Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0164
CY2023Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0164
CY2022Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0164
CY2023Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0164
CY2020Q3 cdlx Adjustments To Additional Paid In Capital Issuance Of Capped Calls
AdjustmentsToAdditionalPaidInCapitalIssuanceOfCappedCalls
26500000 usd
CY2020Q3 us-gaap Option Indexed To Issuers Equity Strike Price1
OptionIndexedToIssuersEquityStrikePrice1
85.14
CY2020Q3 cdlx Option Indexed To Issuers Equity Cap Price
OptionIndexedToIssuersEquityCapPrice
128.51
CY2023Q3 cdlx Line Of Credit Facility Maximum Borrowing Capacity Percentage Of Eligible Accounts Receivable
LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleAccountsReceivable
0.50
CY2023Q3 us-gaap Line Of Credit
LineOfCredit
30000000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
405830 shares
CY2023Q3 cdlx Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Annual Percentage Increase
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedAnnualPercentageIncrease
0.05
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1673858 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
6107000 shares
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
396200000 usd
CY2023Q2 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
18987000 usd
CY2021Q4 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
232295000 usd
CY2022Q4 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
104121000 usd
CY2022Q3 us-gaap Increase Decrease In Due To Affiliates Current
IncreaseDecreaseInDueToAffiliatesCurrent
0 usd
CY2023Q3 us-gaap Increase Decrease In Due To Affiliates Current
IncreaseDecreaseInDueToAffiliatesCurrent
0 usd
us-gaap Increase Decrease In Due To Affiliates Current
IncreaseDecreaseInDueToAffiliatesCurrent
0 usd
us-gaap Increase Decrease In Due To Affiliates Current
IncreaseDecreaseInDueToAffiliatesCurrent
-61808000 usd
CY2022Q3 us-gaap Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-46126000 usd
CY2023Q3 us-gaap Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
8281000 usd
us-gaap Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-114144000 usd
us-gaap Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-15045000 usd
CY2022Q3 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
118151000 usd
CY2023Q3 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
27268000 usd
CY2023Q3 cdlx First Anniversary Annualized Recurring Revenue Cash Paid
FirstAnniversaryAnnualizedRecurringRevenueCashPaid
50100000 usd
CY2023Q3 cdlx Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Delivered
BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesDelivered
2740418 shares
CY2020Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
230000000 usd
CY2020Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0100
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
6267000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-23966000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-86985000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-33866000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32950000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37982000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33455000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35502000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33269000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37982000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33455000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35502000 shares
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.60
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.95
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2022Q3 cdlx Adjusted Contribution
AdjustedContribution
35143000 usd
CY2023Q3 cdlx Adjusted Contribution
AdjustedContribution
42861000 usd
cdlx Adjusted Contribution
AdjustedContribution
103043000 usd
cdlx Adjusted Contribution
AdjustedContribution
111339000 usd
CY2022Q3 cdlx Financial Institution Share And Oth0er Third Party Costs Excluding Non Cash Equity Expense And Deferred Implementation Costs
FinancialInstitutionShareAndOth0erThirdPartyCostsExcludingNonCashEquityExpenseAndDeferredImplementationCosts
37563000 usd
CY2023Q3 cdlx Financial Institution Share And Oth0er Third Party Costs Excluding Non Cash Equity Expense And Deferred Implementation Costs
FinancialInstitutionShareAndOth0erThirdPartyCostsExcludingNonCashEquityExpenseAndDeferredImplementationCosts
36144000 usd
cdlx Financial Institution Share And Oth0er Third Party Costs Excluding Non Cash Equity Expense And Deferred Implementation Costs
FinancialInstitutionShareAndOth0erThirdPartyCostsExcludingNonCashEquityExpenseAndDeferredImplementationCosts
112996000 usd
cdlx Financial Institution Share And Oth0er Third Party Costs Excluding Non Cash Equity Expense And Deferred Implementation Costs
FinancialInstitutionShareAndOth0erThirdPartyCostsExcludingNonCashEquityExpenseAndDeferredImplementationCosts
108698000 usd
CY2022Q3 us-gaap Revenues
Revenues
72706000 usd
CY2023Q3 us-gaap Revenues
Revenues
79005000 usd
us-gaap Revenues
Revenues
216039000 usd
us-gaap Revenues
Revenues
220037000 usd
CY2022Q3 cdlx Adjusted Contribution
AdjustedContribution
35143000 usd
CY2023Q3 cdlx Adjusted Contribution
AdjustedContribution
42861000 usd
cdlx Adjusted Contribution
AdjustedContribution
103043000 usd
cdlx Adjusted Contribution
AdjustedContribution
111339000 usd
CY2022Q3 cdlx Delivery Costs
DeliveryCosts
9125000 usd
CY2023Q3 cdlx Delivery Costs
DeliveryCosts
7012000 usd
cdlx Delivery Costs
DeliveryCosts
23820000 usd
cdlx Delivery Costs
DeliveryCosts
20451000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18289000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14161000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
57920000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
43314000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13762000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12430000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39634000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38841000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19972000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15561000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61381000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44907000 usd
CY2022Q3 cdlx Acquisition And Integration Costs Benefit
AcquisitionAndIntegrationCostsBenefit
-1867000 usd
CY2023Q3 cdlx Acquisition And Integration Costs Benefit
AcquisitionAndIntegrationCostsBenefit
78000 usd
cdlx Acquisition And Integration Costs Benefit
AcquisitionAndIntegrationCostsBenefit
-4269000 usd
cdlx Acquisition And Integration Costs Benefit
AcquisitionAndIntegrationCostsBenefit
-8146000 usd
CY2022Q3 cdlx Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-46126000 usd
CY2023Q3 cdlx Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
8281000 usd
cdlx Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-114144000 usd
cdlx Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-15045000 usd
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
83149000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10468000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5990000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
30695000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
19765000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5253000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3314000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13288000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1118000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6267000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23966000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-88431000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33866000 usd
CY2022Q3 us-gaap Revenues
Revenues
72706000 usd
CY2023Q3 us-gaap Revenues
Revenues
79005000 usd
us-gaap Revenues
Revenues
216039000 usd
us-gaap Revenues
Revenues
220037000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5916000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3005000 usd

Files In Submission

Name View Source Status
cdlx-20230930_cal.xml Edgar Link unprocessable
cdlx-20230930_def.xml Edgar Link unprocessable
0001666071-23-000150-index-headers.html Edgar Link pending
0001666071-23-000150-index.html Edgar Link pending
0001666071-23-000150.txt Edgar Link pending
0001666071-23-000150-xbrl.zip Edgar Link pending
cdlx-20230930.htm Edgar Link pending
cdlx-20230930.xsd Edgar Link pending
cdlx-20230930_g1.jpg Edgar Link pending
cdlx_form10-qx2023q3xex311.htm Edgar Link pending
cdlx_form10-qx2023q3xex312.htm Edgar Link pending
cdlx_form10-qx2023q3xex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
cdlx-20230930_lab.xml Edgar Link unprocessable
cdlx-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cdlx-20230930_htm.xml Edgar Link completed
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending